ZA838065B - Derivatives of piperidenedione,process for preparing them and drugs containing said derivatives - Google Patents

Derivatives of piperidenedione,process for preparing them and drugs containing said derivatives

Info

Publication number
ZA838065B
ZA838065B ZA838065A ZA838065A ZA838065B ZA 838065 B ZA838065 B ZA 838065B ZA 838065 A ZA838065 A ZA 838065A ZA 838065 A ZA838065 A ZA 838065A ZA 838065 B ZA838065 B ZA 838065B
Authority
ZA
South Africa
Prior art keywords
derivatives
drugs containing
piperidenedione
preparing
represent
Prior art date
Application number
ZA838065A
Other languages
English (en)
Inventor
Claude Bernhart
Werner Cautreels
Patrick Gautier
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA838065B publication Critical patent/ZA838065B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA838065A 1982-11-08 1983-10-28 Derivatives of piperidenedione,process for preparing them and drugs containing said derivatives ZA838065B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8218706A FR2535721A1 (fr) 1982-11-08 1982-11-08 Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives

Publications (1)

Publication Number Publication Date
ZA838065B true ZA838065B (en) 1984-06-27

Family

ID=9279000

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA838065A ZA838065B (en) 1982-11-08 1983-10-28 Derivatives of piperidenedione,process for preparing them and drugs containing said derivatives

Country Status (29)

Country Link
US (1) US4721710A (da)
EP (1) EP0110755B1 (da)
JP (1) JPS59161377A (da)
KR (1) KR900006721B1 (da)
AT (1) ATE22561T1 (da)
AU (1) AU565519B2 (da)
CA (1) CA1221967A (da)
CS (1) CS244681B2 (da)
DD (3) DD229407A5 (da)
DE (1) DE3366623D1 (da)
DK (1) DK511383A (da)
ES (1) ES527091A0 (da)
FI (1) FI79536C (da)
FR (1) FR2535721A1 (da)
GR (1) GR78747B (da)
HU (1) HU191494B (da)
IE (1) IE56209B1 (da)
IL (1) IL70099A (da)
MA (1) MA19948A1 (da)
NO (1) NO159852C (da)
NZ (1) NZ206177A (da)
OA (1) OA07582A (da)
PH (1) PH20421A (da)
PL (3) PL139946B1 (da)
PT (1) PT77607B (da)
SG (1) SG1989G (da)
SU (3) SU1333237A3 (da)
YU (3) YU221183A (da)
ZA (1) ZA838065B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668689A (en) * 1984-07-19 1987-05-26 National Research Development Corporation Glutarimide derivatives for treating oestrogen-dependent tumors
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
DE19703763C1 (de) * 1997-02-01 1998-10-01 Gruenenthal Gmbh Thalidomidanaloge Verbindungen aus der Klasse der Piperidin-2,6-Dione
WO2012158795A1 (en) 2011-05-17 2012-11-22 Principia Biopharma Inc. Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
EA025496B1 (ru) 2011-05-17 2016-12-30 Принсипиа Биофарма Инк. Ингибиторы тирозинкиназы
HUE048834T2 (hu) 2011-05-17 2020-08-28 Univ California Kináz inhibitorok
US9266895B2 (en) 2012-09-10 2016-02-23 Principia Biopharma Inc. Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors
US8957080B2 (en) 2013-04-09 2015-02-17 Principia Biopharma Inc. Tyrosine kinase inhibitors
EP4681737A3 (en) 2014-02-21 2026-03-11 Principia Biopharma Inc. Salts and solid form of a btk inhibitor
US10485797B2 (en) 2014-12-18 2019-11-26 Principia Biopharma Inc. Treatment of pemphigus
TW201718572A (zh) 2015-06-24 2017-06-01 普林斯匹亞生物製藥公司 酪胺酸激酶抑制劑
IL293621B2 (en) 2016-06-29 2023-09-01 Principia Biopharma Inc Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[4,3-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4 -Methyl-4-[4-(oxane-3-yl)piperazine-1-yl)penta-2-ananitrile
JP7795454B2 (ja) 2019-10-14 2026-01-07 プリンシピア バイオファーマ インコーポレイテッド (r)-2-[3-[4-アミノ-3-(2-フルオロ-4-フェノキシ-フェニル)ピラゾロ[3,4-d]ピリミジン-1-イル]ピペリジン-1-カルボニル]-4-メチル-4-[4-(オキセタン-3-イル)ピペラジン-1-イル]ペンタ-2-エンニトリルを投与することにより免疫性血小板減少症を治療する方法
AU2021209884A1 (en) 2020-01-22 2022-09-15 Principia Biopharma Inc. Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2664424A (en) * 1953-12-29 Dioxo-piperidines
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
FR2467200A1 (fr) * 1979-10-11 1981-04-17 Clin Midy Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire

Also Published As

Publication number Publication date
PL249750A1 (en) 1985-03-12
GR78747B (da) 1984-10-02
IL70099A0 (en) 1984-01-31
PT77607B (fr) 1986-03-18
EP0110755A1 (fr) 1984-06-13
OA07582A (fr) 1985-03-31
SG1989G (en) 1989-06-02
ES8406070A1 (es) 1984-07-01
PL140021B1 (en) 1987-03-31
US4721710A (en) 1988-01-26
JPS59161377A (ja) 1984-09-12
IE56209B1 (en) 1991-05-22
IE832581L (en) 1984-05-08
FR2535721B1 (da) 1985-05-17
FI79536C (fi) 1990-01-10
CA1221967A (en) 1987-05-19
CS244681B2 (en) 1986-08-14
SU1333237A3 (ru) 1987-08-23
FI79536B (fi) 1989-09-29
KR840006641A (ko) 1984-12-01
ES527091A0 (es) 1984-07-01
YU184285A (en) 1986-06-30
MA19948A1 (fr) 1984-07-01
PL244462A1 (en) 1985-02-13
ATE22561T1 (de) 1986-10-15
NO159852C (no) 1989-02-15
DE3366623D1 (en) 1986-11-06
FR2535721A1 (fr) 1984-05-11
YU221183A (en) 1986-06-30
YU184185A (en) 1986-06-30
DK511383A (da) 1984-05-09
NZ206177A (en) 1985-11-08
PH20421A (en) 1987-01-05
AU565519B2 (en) 1987-09-17
KR900006721B1 (ko) 1990-09-20
FI834087A0 (fi) 1983-11-08
PL139946B1 (en) 1987-03-31
IL70099A (en) 1987-10-20
HU191494B (en) 1987-02-27
PL249749A1 (en) 1985-03-12
AU2089883A (en) 1984-05-17
DD219770A5 (de) 1985-03-13
SU1333238A3 (ru) 1987-08-23
NO159852B (no) 1988-11-07
PT77607A (fr) 1983-12-01
FI834087L (fi) 1984-05-09
EP0110755B1 (fr) 1986-10-01
PL140992B1 (en) 1987-06-30
NO834057L (no) 1984-05-09
DD229407A5 (de) 1985-11-06
SU1316558A3 (ru) 1987-06-07
DK511383D0 (da) 1983-11-08
DD229402A5 (de) 1985-11-06

Similar Documents

Publication Publication Date Title
PL249749A1 (en) Process for preparing novel derivatives of piperidinedione
HUT60734A (en) Process for producing substituted azoles and pharmaceutical compositions comprising such compounds
HUT68166A (en) Process for preparing substituted piperidines
PL293392A1 (en) Method of obtaining novel derivatives of 3-aminopiperidine
DK357482A (da) Fremgangsmaade til fremstilling af 4-methyl-6-phenyl-pyridazinderivater
EP0280946A3 (en) Organosilanes containing benzoylthiourea; process for their preparation
DE3160360D1 (en) 5-subsituted 5,10-dihydro-11h-dibenzo(b,e)(1,4)diazepin-11-ones, process for preparing them and medicaments containing them
ES8501771A1 (es) Procedimiento para la preparacion de un nuevo compuesto heterociclico
HUT50142A (en) Process for producing allyl-mercapto-acetyl-sidnonimine derivatives and pharmaceutical compositions containing them
CS859582A2 (en) Zpusob pripravy cefalosporinu
FI830338L (fi) Foerfarande foer framstaellning av piperazinyl-4 fenyl-4 kinatsolin derivat
HUT48891A (en) Process for producing substituted vinyl-cephalosporines and pharmaceutical compositions containing t them
DE3564426D1 (en) Polyprenyl compound, process of producing it and pharmaceutical use
ZA828491B (en) Alkylcycloalkyl imidazolylmethyl ketones and a process for their preparation
AT383811B (de) Verfahren zur herstellung von monoalkalisalzen von 7-amino-3-cephem-4-carbonsaeurederivaten
CS821983A2 (en) Zpusob pripravy derivatu gama-butyrolaktonu